Valuation: MedPacto, Inc.

Market Cap 13TCr 9.34Cr 8.51Cr 7.84Cr 7.13Cr 13Cr 864.71Cr 14Cr 95Cr 38Cr 472.3Cr 35Cr 34Cr 1.48TCr P/E 2024
-7.42x
P/E 2025 -17.9x
Enterprise Value 8.63TCr 6.43Cr 5.86Cr 5.4Cr 4.91Cr 9.21Cr 595.7Cr 9.68Cr 66Cr 26Cr 325.37Cr 24Cr 24Cr 1.02TCr EV / Sales 2024
-
EV / Sales 2025 4,87,33,025x
Free-Float
74%
Yield 2024 *
-
Yield 2025 -
1 day-2.66%
1 week-14.20%
Current month+19.84%
1 month+7.82%
3 months+41.12%
6 months-8.62%
Current year-45.28%
1 week 3,585
Extreme 3585.00000000
4,340
1 month 2,865
Extreme 2865
5,100
Current year 2,235
Extreme 2235
7,980
1 year 2,235
Extreme 2235
8,210
3 years 2,235
Extreme 2235
17,240
5 years 2,235
Extreme 2235
69,600
10 years 2,235
Extreme 2235
1,34,200
Manager TitleAgeSince
Chief Executive Officer 72 19/06/2013
President 66 28/03/2024
Comptroller/Controller/Auditor 70 28/03/2022
Director TitleAgeSince
Director/Board Member 72 19/06/2013
Director/Board Member 66 28/03/2024
Director/Board Member 64 28/03/2024
Date Insider Type Main position Quantity % Market Cap. Importance
04/03/25 Buy 10,000 0.0292%
04/03/25 Buy 10,500 0.0306%
04/03/25 Buy

Chairperson

15,000 0.0438%
Change 5-day change 1-year change 3-year change Capi.($)
-2.66%-14.20%-51.33%-52.10% 9.34Cr
-2.49%-3.76%+50.31%+62.10% 6.37TCr
-0.63%-2.91%+6.20%+89.22% 5.86TCr
-2.37%-2.22%+22.87%+82.31% 5.42TCr
-2.19%-6.15%+11.92%+108.08% 4.47TCr
-1.89%-7.28%+13.22%+19.74% 4.05TCr
-0.93%-0.47%+19.73%+43.75% 3.63TCr
+1.11%-6.44%+130.68%+641.83% 3.49TCr
-0.80%+0.61%+77.26%+56.26% 3.23TCr
-2.17%+16.65%-29.21%+474.05% 3.1TCr
Average -1.50%-1.64%+25.17%+152.52% 4TCr
Weighted average by Cap. -1.48%-1.85%+32.14%+150.85%

Financials

2024 2025
Net sales - 3.9T 2.91 2.65 2.44 2.22 4.16 269.09 4.37 29.68 11.8 146.98 10.9 10.67 461.27
Net income -2.01TCr -1.5Cr -1.37Cr -1.26Cr -1.15Cr -2.15Cr -139.02Cr -2.26Cr -15Cr -6.09Cr -76Cr -5.63Cr -5.51Cr -238.3Cr -1.28TCr -95.49L -86.97L -80.14L -72.9L -1.37Cr -88Cr -1.44Cr -9.75Cr -3.88Cr -48Cr -3.58Cr -3.51Cr -151.58Cr
Net Debt -5.35TCr -3.99Cr -3.63Cr -3.35Cr -3.05Cr -5.72Cr -369.54Cr -6.01Cr -41Cr -16Cr -201.84Cr -15Cr -15Cr -633.47Cr -3.9TCr -2.91Cr -2.65Cr -2.44Cr -2.22Cr -4.16Cr -269.01Cr -4.37Cr -30Cr -12Cr -146.93Cr -11Cr -11Cr -461.13Cr
Projected Income Statement - Annual - MedPacto, Inc.
Logo MedPacto, Inc.
MedPacto, Inc. is a Korea-based company principally engaged in the research and development of biopharmaceuticals. The Company researches and develops anticancer drugs and diagnostic kits including vactosertib, MA-B2 and others. The products are used as the treatment of multiple myeloma, lung cancer, stomach cancer, colon cancer, blood cancer, triple negative breast cancer and pancreatic cancer, among others.
Employees
56
Date Price Change Volume
20/26/20 ₩3,655.00 -2.66% 2,09,554
19/26/19 ₩3,755.00 +0.13% 1,91,160
18/26/18 ₩3,750.00 -2.34% 3,38,332
17/26/17 ₩3,840.00 -0.65% 3,72,915
16/26/16 ₩3,865.00 -9.27% 7,34,592
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
CCC

Net sales - Rate of surprise

Rate of surprise - Net sales - Annual - MedPacto, Inc.
  1. Stock Market
  2. Stocks
  3. A235980 Stock